The neuroprotective effect of tetrahydrobiopterin
四氢生物蝶呤的神经保护作用
基本信息
- 批准号:7220615
- 负责人:
- 金额:$ 32.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-04-01 至 2009-03-31
- 项目状态:已结题
- 来源:
- 关键词:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine1-Methyl-4-phenylpyridinium14pAccountingAgingAntioxidantsApoptosisAttenuatedBioenergeticsBrainButhionine SulfoximineCell DeathCell Death Signaling ProcessCell LineCell SurvivalCessation of lifeCharacteristicsChronicCompatibleComplementConflict (Psychology)Corpus striatum structureDataDisease modelDisruptionDopamineDopaminergic CellElectron TransportEnzymesEtiologyExposure toFibroblastsFigs - dietaryFluorescenceGTP CyclohydrolaseGenerationsGlutamatesGlutathioneIn VitroIncidenceIndividualInjection of therapeutic agentLifeMeasurementMediatingMembraneMembrane PotentialsMitochondriaModelingMusNeuronsNitric OxideNitric Oxide SynthaseNumbersOxidative PhosphorylationOxidative StressParaquatParkinson DiseasePathogenesisPathway interactionsPeroxidesPhysiologicalProductionReactive Oxygen SpeciesReduced GlutathioneResearch PersonnelResistanceRespirationRoleRotenoneSignal TransductionSliceSubstantia nigra structureSulfhydryl CompoundsSuperoxidesSystemTestingThioredoxinToxic effectTyrosine 3-MonooxygenaseVentral Tegmental Areaadeno-associated viral vectorbuthioninecofactorcytochrome cdopaminergic neuronin vivoin vivo Modelinhibitor/antagonistmitochondrial dysfunctionmitochondrial membranemouse modelneuron lossneuronal survivaloxidationpars compactapreventprogramstetrahydrobiopterin
项目摘要
DESCRIPTION (provided by applicant): While multiple etiologies are likely to account for Parkinson's disease (PD), the core pathogenic feature is degeneration of dopaminergic neurons, particularly those in the substantia nigra pars compacta (SNpc), with shared common final pathways involving oxidative damage, mitochondrial dysfunction, or both. Therefore, one may hypothesize that dopaminergic neurons in the SNpc are selectively vulnerable to oxidative stresses and/or mitochondrial disruption and understanding the mechanism of this selectivity may reveal the pathogenesis. However, our data show that ventral mesencephalic dopaminergic neurons in culture have an enhanced antioxidant capacity, as they are better able to resist oxidative stresses such as glutathione depletion and peroxide treatment than nondopaminergic neurons. In addition, their enhanced antioxidant capacity is reflected in lower reactive oxygen species (ROS) and higher reduced glutathione levels than nondopaminergic neurons. We hypothesize that an enhanced antioxidant capacity is essential for the survival of dopaminergic neurons that may be subjected to increased oxidative stress exerted by dopamine and its metabolites. We postulate that disruption of this innate antioxidant capacity makes them vulnerable to additional environmental insults and thereby leads to selective degeneration. We noted that the enhanced antioxidant capacity in ventral mesencephalic dopaminergic neurons is due to tetrahydrobiopterin (BH4), which is the cofactor for tyrosine hydroxylase, the enzyme producing dopamine, but also lowers superoxide levels, partly be direct scavenging effect and modulates mitochondrial function. First, We will study the effect of BH4 on mitochondrial bioenergetics and function including initiation of death pathways. Second, we will examine the role of BH4 on NO and superoxide generation and in modulating other endogenous antioxidant systems. Third, the neuroprotective function of BH4 against PD models such as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, rotenone toxicity, and glutathione depletion will be tested in vivo and in organotypic slice cultures, using hph-1 mice that are deficient in BH4, production.
描述(由申请人提供):虽然多种病因可能是帕金森病(PD)的原因,但核心致病特征是多巴胺能神经元变性,特别是黑质丘脑部(SNpc)中的多巴胺能神经元变性,具有共同的最终通路,涉及氧化损伤、线粒体功能障碍或两者兼而有之。因此,可以假设SNpc中的多巴胺能神经元选择性地易受氧化应激和/或线粒体破坏的影响,并且理解这种选择性的机制可以揭示发病机制。然而,我们的数据表明,腹侧中脑多巴胺能神经元在文化中具有增强的抗氧化能力,因为它们能够更好地抵抗氧化应激,如谷胱甘肽耗竭和过氧化物处理比nondopaminergic神经元。此外,它们增强的抗氧化能力反映在较低的活性氧(ROS)和较高的还原型谷胱甘肽水平比非多巴胺能神经元。我们推测,增强的抗氧化能力是必不可少的多巴胺能神经元的生存,可能会受到多巴胺及其代谢产物产生的氧化应激增加。我们假设,这种先天的抗氧化能力的破坏,使他们容易受到额外的环境侮辱,从而导致选择性退化。我们注意到,腹侧中脑多巴胺能神经元的抗氧化能力增强是由于四氢生物蝶呤(BH 4),这是酪氨酸羟化酶,产生多巴胺的酶的辅因子,但也降低超氧化物水平,部分是直接清除作用和调节线粒体功能。首先,我们将研究BH 4对线粒体生物能量学和功能的影响,包括启动死亡途径。其次,我们将研究BH 4对NO和超氧化物生成以及调节其他内源性抗氧化系统的作用。第三,BH 4对PD模型如1-甲基-4-苯基-1,2,3,6-四氢吡啶、鱼藤酮毒性和谷胱甘肽耗竭的神经保护功能将在体内和器官型切片培养中使用BH 4产生缺陷的hph-1小鼠进行测试。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Characterization of PINK1 processing, stability, and subcellular localization.
- DOI:10.1111/j.1471-4159.2008.05398.x
- 发表时间:2008-07
- 期刊:
- 影响因子:4.7
- 作者:Lin W;Kang UJ
- 通讯作者:Kang UJ
Paraquat induces dopaminergic dysfunction and proteasome impairment in DJ-1-deficient mice.
- DOI:10.1093/hmg/ddm249
- 发表时间:2007-12
- 期刊:
- 影响因子:3.5
- 作者:Wonsuk Yang;Linan Chen;Yunmin Ding;X. Zhuang;U. Kang
- 通讯作者:Wonsuk Yang;Linan Chen;Yunmin Ding;X. Zhuang;U. Kang
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Un Jung Kang其他文献
Defining the molecular identity and morphology of emglia limitans superficialis/em astrocytes in vertebrates
定义脊椎动物浅部神经胶质界膜/星形胶质细胞的分子特性和形态
- DOI:
10.1016/j.celrep.2025.115344 - 发表时间:
2025-03-25 - 期刊:
- 影响因子:6.900
- 作者:
Philip Hasel;Melissa L. Cooper;Anne E. Marchildon;Uriel Rufen-Blanchette;Rachel D. Kim;Thong C. Ma;Adam M.R. Groh;Emily J. Hill;Eleanor M. Lewis;Michał Januszewski;Sarah E.W. Light;Cody J. Smith;Jo Anne Stratton;Steven A. Sloan;Un Jung Kang;Moses V. Chao;Shane A. Liddelow - 通讯作者:
Shane A. Liddelow
CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses.
通过重组复制缺陷型腺病毒逆行转运进行中枢神经系统基因递送。
- DOI:
- 发表时间:
1995 - 期刊:
- 影响因子:5.1
- 作者:
G. Ghadge;Raymond P. Roos;Un Jung Kang;Robert L. Wollmann;Fishman Ps;Kalynych Am;E. Barr;Jeffrey M. Leiden - 通讯作者:
Jeffrey M. Leiden
New diagnostic and staging framework applied to established PD in the BioFIND cohort
新的诊断和分期框架应用于 BioFIND 队列中已确诊的 PD
- DOI:
10.1038/s41531-025-00992-3 - 发表时间:
2025-06-04 - 期刊:
- 影响因子:8.200
- 作者:
Marco J. Russo;Un Jung Kang - 通讯作者:
Un Jung Kang
Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis
帕金森病的疾病修饰疗法:来自多发性硬化症的经验教训
- DOI:
10.1038/s41582-024-01023-0 - 发表时间:
2024-10-07 - 期刊:
- 影响因子:33.100
- 作者:
Lorraine V. Kalia;Angelica Asis;Nathalie Arbour;Amit Bar-Or;Riley Bove;Daniel G. Di Luca;Edward A. Fon;Susan Fox;Ziv Gan-Or;Jennifer L. Gommerman;Un Jung Kang;Eric C. Klawiter;Marcus Koch;Shannon Kolind;Anthony E. Lang;Karen K. Lee;Matthew R. Lincoln;Penny A. MacDonald;Martin J. McKeown;Tiago A. Mestre;Veronique E. Miron;Daniel Ontaneda;Maxime W. C. Rousseaux;Michael G. Schlossmacher;Raphael Schneider;A. Jon Stoessl;Jiwon Oh - 通讯作者:
Jiwon Oh
Aerobic exercise-induced changes in fluid biomarkers in Parkinson’s disease
帕金森病中有氧运动引起的液体生物标志物的变化
- DOI:
10.1038/s41531-025-01042-8 - 发表时间:
2025-07-01 - 期刊:
- 影响因子:8.200
- 作者:
Nijee S. Luthra;Niyati Mehta;Miranda J. Munoz;Giamila Fantuzzi;Guillaume Lamotte;Jacob M. Haus;Nikolaus R. McFarland;Malú G. Tansey;Paulina Gonzalez-Latapi;Gabriela Caraveo;Un Jung Kang;Daniel M. Corcos - 通讯作者:
Daniel M. Corcos
Un Jung Kang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Un Jung Kang', 18)}}的其他基金
Single Cell Transcriptomic Profiling of Multiple System Atrophy Brain
多系统萎缩脑的单细胞转录组分析
- 批准号:
10799995 - 财政年份:2023
- 资助金额:
$ 32.69万 - 项目类别:
Pathological striatopallidal neuronalensembles in learned motor impairment in PD
PD 习得性运动障碍中的病理性纹状体苍白球神经元群
- 批准号:
10395604 - 财政年份:2018
- 资助金额:
$ 32.69万 - 项目类别:
Pathological striatopallidal neuronalensembles in learned motor impairment in PD
PD 习得性运动障碍中的病理性纹状体苍白球神经元群
- 批准号:
9578625 - 财政年份:2018
- 资助金额:
$ 32.69万 - 项目类别:
Pathological striatopallidal neuronalensembles in learned motor impairment in PD
PD 习得性运动障碍中的病理性纹状体苍白球神经元群
- 批准号:
10165842 - 财政年份:2018
- 资助金额:
$ 32.69万 - 项目类别:
Pathological striatopallidal neuronalensembles in learned motor impairment in PD
PD 习得性运动障碍中的病理性纹状体苍白球神经元群
- 批准号:
9895051 - 财政年份:2018
- 资助金额:
$ 32.69万 - 项目类别:
The striatal cholinergic interneurons in Parkinson's disease and treatment
纹状体胆碱能中间神经元在帕金森病及其治疗中的作用
- 批准号:
9333674 - 财政年份:2017
- 资助金额:
$ 32.69万 - 项目类别:
The striatal cholinergic interneurons in Parkinson's disease and treatment
纹状体胆碱能中间神经元在帕金森病及其治疗中的作用
- 批准号:
9894969 - 财政年份:2017
- 资助金额:
$ 32.69万 - 项目类别:
Plasticity of bridge collaterals in Parkinonian state and treatment
帕金森状态下桥络的可塑性及治疗
- 批准号:
9092007 - 财政年份:2016
- 资助金额:
$ 32.69万 - 项目类别:
The role of striatal cholinergic interneurons in Parkinson’s disease
纹状体胆碱能中间神经元在帕金森病中的作用
- 批准号:
9147020 - 财政年份:2015
- 资助金额:
$ 32.69万 - 项目类别:
Striatal cholinergic neurons and L-DOPA induced dyskinesia
纹状体胆碱能神经元和左旋多巴诱导的运动障碍
- 批准号:
8693110 - 财政年份:2009
- 资助金额:
$ 32.69万 - 项目类别:














{{item.name}}会员




